agm

Another Turbulent AGM for Bayer?

Bayer has seen its share of turbulent shareholder meetings, and the event on Apr. 28 is likely to continue in that vein, though it would be tough to top 2019. In that year, when anger over lawsuits involving Monsanto’s Roundup herbicide boiled over, 55% voted not to discharge CEO Werner Baumann and the managing board of their responsibilities.

Bayer AGM Sees Discussion on Multiple Fronts

Like those of other chemical industry players, shareholders attending Bayer’s virtual annual general meeting on Apr. 29 had a full agenda to deal with, though their list was undoubtedly one of the longest. Along with the Russian invasion of Ukraine, they discussed potential plans to split pharma and crop science, the timetable for finally ending Roundup litigation and the size of executives’ bonuses.

Bayer AGM Censures Leaders for Monsanto Woes

Linde Leaders Face Criticism at AGM

Kreimeyer to Lead K+S Supervisory Board